Vanguard Fiduciary Trust
NERV icon

Vanguard Fiduciary Trust’s Minerva Neurosciences NERV Stock Holding History

Vanguard Fiduciary Trust’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Buy
302,604
+38,557
+15% +$209K ﹤0.01% 2765
2026
Q1 		$1.59M Buy
+264,047
New +$1.51M ﹤0.01% 2687

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust's NERV Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Minerva Neurosciences (NERV) stake by 15% in Q2 2026, buying an estimated $209K and bringing the position to 302,604 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #2765.

Vanguard Fiduciary Trust first reported a position in NERV in Q1 2026 and has held it in 2 quarters since. 60 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • Vanguard Fiduciary Trust held 302,604 shares of Minerva Neurosciences worth $1.68M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 38,557 Minerva Neurosciences shares in Q2 2026, an estimated $209K.
  • Minerva Neurosciences made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2765 holding.
  • Vanguard Fiduciary Trust first reported a position in Minerva Neurosciences in Q1 2026 and has held it in 2 quarters since.
  • 60 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.